BridgeBio Pharma (BBIO) P/E ratio

There is no P/E ratio history on record here for BridgeBio Pharma (BBIO). Figures as of 19 Nov 2026, 06:13 UTC, from the company's filings with the SEC and Yahoo Finance.

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Not enough data

A history of P/E ratio needs at least 3 fiscal years; none is on record here for BridgeBio Pharma. Nothing is estimated to fill the gap. What is on record is in the table below.

BridgeBio Pharma P/E ratio, year by year

BridgeBio Pharma (BBIO) P/E ratio by fiscal year
Fiscal yearP/E ratioChangeYear endedShare price at year-endDiluted EPS
2025——$76.49-$3.78
2024——$27.44-$2.88
2023——$40.37-$3.95
2022——$7.62-$3.26
2021——$16.68-$3.90
2020——$71.11-$3.80
2019——$35.05—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E.

How to read it

It is the number of years of current profit the price pays for — a high figure means investors expect growth, and it is best judged against the company's own history.

P/E ratio at health care companies of similar size

P/E ratio of BridgeBio Pharma and comparable companies
CompanyP/E ratio
ICON ICLR78.1×
Jazz Pharmaceuticals JAZZ73.3×
Solventum SOLV97.2×

Price over the last twelve months' earnings per share, as the market data feed reports it.

More on BBIO

BridgeBio Pharma, figure by figure

BridgeBio Pharma (BBIO) overview: price, valuation and scorecardAll health care companies by market value

BridgeBio Pharma P/E ratio: questions and answers

How is BridgeBio Pharma's P/E ratio calculated?

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “BridgeBio Pharma (BBIO) P/E ratio”, data as of 19 November 2026. https://funkfolio.com/stock/BBIO/pe-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.